Public Board of Directors papers 27.01.22

KW asked whether there will be an opportunity for those who have donated to be part of the opening of the centre. RS responded that there is a plan to do this within the current restrictions. BD noted that there will be an opportunity to provide detail on the benefits for patients through patient experience surveys etc. BD noted that this is in the business case requirements. RF noted that the School of Oncology would be interested in the centre leading education sessions and that this will be explored. Further facilities were shown including the research room, the physics room for planning, office space and the seminar room. This room will be used for health & wellbeing events, physiotherapy as well as staff training. CO noted that it is great to see education and research codesigned into the centre. CO thanked BD & SK and all the members of staff who participated for the tour and opportunity to see the fantastic new centre. Item Action 38/21 Standard business a Apologies Apologies were received from Fiona Blackhall (FB), Director of Research b Declarations of Interest No declarations of interest noted. c Minutes of the previous meeting – 28 th October 2021 The minutes were accepted as a correct record.

d Action plan rolling programme, action log & matters arising All items from the rolling programme are noted on the agenda. 39/21 Key Reports a Chief executive’s report

RS outlined the current situation report on site. We are in level 2 escalation, operating as business as usual but with a prevalence of covid as well as delivering cancer treatments. We continue to deliver treatments for patients who used to be treated elsewhere in Greater Manchester. RS noted the patient safety specialist role that is now in place in the trust and pointed to the details in the report. We are implementing a dedicated patient safety role in line with national requirements, more information will come to future meetings. RS noted the update on our developments in his report. No further comments or questions were raised. CO thanked RS.

b Integrated performance, quality & finance report BD outlined the key points from the report for month 5. Safe

• Two serious incidents and eight moderate incidents were reported in October. All the incidents are still progressing through to full root cause

analysis. No never events were reported in month. • There are seven Trust level risks scored at 15+. Responsive / Access

4